Natural Alternatives International, Inc.

NasdaqGM:NAII

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏬 Consumer Packaged Goods

💊 Pharmaceuticals

Location

United States

Market Cap

USD 24.59 M

Share Price

USD 3.98

Avg Daily Volume

3,972

Change (1 day)

0.51%

Change (1 year)

-28.42%

Change (YTD)

-7.66%

Natural Alternatives International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -6.11 M

Natural Alternatives International, Inc. EBITDA is USD -6.11 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -692.73% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Natural Alternatives International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.03 M, a -90.86% change year over year.
Natural Alternatives International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 11.28 M, a -51.60% change year over year.
Natural Alternatives International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 23.31 M, a 47.46% change year over year.
Natural Alternatives International, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 15.81 M, a 2,309.76% change year over year.